Date published: 2026-6-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

GTAM2 Marker Antibody (B43.2): sc-59193

2.0(1)
Write a reviewAsk a question

Datasheets
  • GTAM2 Marker Antibody (B43.2) is a mouse monoclonal IgG1 provided at 500 µl supernatant
  • raised against GTAM2 of human origin
  • recommended for detection of GTAM2 of human origin by WB, IF and IHC(P)
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for GTAM2 Marker Antibody (B43.2). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    GTAM2 Marker Antibody (B43.2) is a mouse monoclonal IgG1 antibody that detects GTAM2 protein of human origin by western blotting (WB), immunofluorescence (IF), and immunohistochemistry with paraffin-embedded sections (IHCP). Anti-GTAM2 antibody (B43.2) is available in a non-conjugated form, providing flexibility for various experimental needs. GTAM2, or gastrointestinal tumor associated marker 2, plays a crucial role in identifying gastric carcinoma, a cancer that can arise in any part of the stomach and metastasize to other organs, including the esophagus and small intestine. GTAM2 monoclonal antibody (B43.2) detects expression in the luminal and apical cytoplasm of pancreatic cancer cells, as well as in lung, colon, and gastric carcinomas, making GTAM2 a valuable marker for malignancy. GTAM2′s presence in tumor tissues helps distinguish between benign and malignant conditions, essential for early diagnosis and effective treatment strategies. GTAM2′s unique expression profile in cancerous tissues highlights potential as a target for therapeutic interventions, as GTAM2 may interact with specific proteins involved in tumor progression and metastasis, offering insights into molecular mechanisms underlying cancer development.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    GTAM2 Marker Antibody (B43.2) References:

    1. Sialosyl-Tn antigen. Its distribution in normal human tissues and expression in adenocarcinomas.  |  Yonezawa, S., et al. 1992. Am J Clin Pathol. 98: 167-74. PMID: 1510031
    2. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.  |  Ho, JJ., et al. 1991. Cancer Res. 51: 372-80. PMID: 1703039
    3. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins.  |  Byrd, JC., et al. 1991. Cancer Res. 51: 1026-33. PMID: 1988113
    4. Cancer-associated alterations of blood group antigen expression in the human pancreas.  |  Itzkowitz, SH., et al. 1987. J Natl Cancer Inst. 79: 425-34. PMID: 2442445
    5. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors.  |  Hilkens, J., et al. 1984. Int J Cancer. 34: 197-206. PMID: 6206003
    6. Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy.  |  Siddiki, B., et al. 1993. Int J Cancer. 54: 467-74. PMID: 7685327
    7. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.  |  Osako, M., et al. 1993. Cancer. 71: 2191-9. PMID: 8384065

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    GTAM2 Marker Antibody (B43.2)

    sc-59193
    500 µl supernatant
    $322.00